116 related articles for article (PubMed ID: 6798252)
1. Immunogenicity of purified Habu snake-venom toxoid in guinea pigs and monkeys with special reference to HR1 component.
Sadahiro S; Omori-Satoh T; Yamauchi K; Kondo S; Ishida S; Murata R
Jpn J Med Sci Biol; 1981 Aug; 34(4):213-30. PubMed ID: 6798252
[TBL] [Abstract][Full Text] [Related]
2. Immune response of man to Habu-venom toxoid.
Murata R; Fukushima H
Jpn J Med Sci Biol; 1981 Aug; 34(4):197-212. PubMed ID: 7321293
[TBL] [Abstract][Full Text] [Related]
3. Effects of adjuvants on the immunogenicity of Habu-venom toxoid in the monkey and the guinea pig.
Sadahiro S; Kondo S; Yamamoto A
Jpn J Med Sci Biol; 1981 Jun; 34(3):169-73. PubMed ID: 6796732
[TBL] [Abstract][Full Text] [Related]
4. Effects of pH and lysine during detoxification of a hemorrhagic principle of Habu snake (Trimeresurus flavoviridis) venom with formalin on the immunogenicity of the toxoid.
Sadahiro S; Omori-Satoh T; Kondo S; Matuhasi T
Jpn J Med Sci Biol; 1984; 37(5-6):225-31. PubMed ID: 6443133
[TBL] [Abstract][Full Text] [Related]
5. [The effect of Habu toxoid--from the view point of public health center].
Uda H; Tomari T; Yanagihashi T; Nozaki M; Kodama K
Nihon Koshu Eisei Zasshi; 1993 Jun; 40(6):482-90. PubMed ID: 8347864
[TBL] [Abstract][Full Text] [Related]
6. Toxoid preparation from venom of Bothrops colombiensis (Central and South American snake).
Rodriquez-Acosta A; Alonso R; Castro I; Aguilar A; Giron ME
Roum Arch Microbiol Immunol; 1991; 50(3):209-14. PubMed ID: 1821162
[TBL] [Abstract][Full Text] [Related]
7. Preparation and standardization of formol toxoid from the venom of Trimeresurus flavoviridis (Habu).
Kondo H; Murata R
Taiwan Yi Xue Hui Za Zhi; 1972 Jun; 71(6):413-9. PubMed ID: 4633952
[No Abstract] [Full Text] [Related]
8. Immunogenicity of a toxoid of Habu (Trimeresurus flavoviridis) venom in various animal species including man.
Kondo H; Sadahiro S; Kondo S; Yamauchi K; Murata R
Jpn J Med Sci Biol; 1971 Dec; 24(6):365-77. PubMed ID: 5003950
[No Abstract] [Full Text] [Related]
9. [Toxoids from the venom of Habu (Trimeresurus flavoviridis). II. Immunogenicity of the purified toxoids].
Sadahiro S
Nihon Saikingaku Zasshi; 1971 Jul; 26(7):319-24. PubMed ID: 5107268
[No Abstract] [Full Text] [Related]
10. Studies on the improvement of treatment of Habu (Trimeresurus flavoviridis) bites. 9. Studies on the immunogenicity of the purified Habu venom toxoid by alcohol precipitation.
Sawai Y; Chinzei H; Kawamura Y; Okonogi T
Taiwan Yi Xue Hui Za Zhi; 1972 Jun; 71(6):421-30. PubMed ID: 4573916
[No Abstract] [Full Text] [Related]
11. Protective effects of clostridium sordellii LT and HT toxoids against challenge with spores in guinea pigs.
Amimoto K; Oishi E; Yasuhar H; Sasak O; Katayama S; Kitajima T; Izumida A; Hirahara T
J Vet Med Sci; 2001 Aug; 63(8):879-83. PubMed ID: 11558543
[TBL] [Abstract][Full Text] [Related]
12. Studies on the improvement of treatment of Habu (Trimeresurus flavoviridis) bites. 9. Studies on the immunogenicity of the purified Habu venom toxoid by alcohol precipitation.
Sawai Y; Chinzei H; Kawamura Y; Fukuyama T; Okonogi T
Jpn J Exp Med; 1972 Apr; 42(2):155-64. PubMed ID: 4537796
[No Abstract] [Full Text] [Related]
13. Developing recombinant phospholipase D1 (rPLD1) toxoid from Iranian Hemiscorpius lepturus scorpion and its protective effects in BALB/c mice.
Safari Foroushani N; Modarressi MH; Behdani M; Torabi E; Pooshang Bagheri K; Shahbazzadeh D
Toxicon; 2018 Sep; 152():30-36. PubMed ID: 29981815
[TBL] [Abstract][Full Text] [Related]
14. Comparative study on the immunogenic properties of Clostridium perfringens type A toxoid.
Shemanova GF; Vlasova EV; Dmitrieva LN; Trapezov EV; Gorbacheva LD
J Hyg Epidemiol Microbiol Immunol; 1986; 30(3):323-9. PubMed ID: 2877025
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of purified toxoid of Habu (Trimeresurus flavoviridis) venom.
Kondo H; Kondo S; Sadahiro S; Yamauchi K; Murata R
Jpn J Med Sci Biol; 1972 Jun; 25(3):202-5. PubMed ID: 4539442
[No Abstract] [Full Text] [Related]
16. Standardization of habu (Trimeresurus flavoviridis) snake-venom toxoid.
Sadahiro S; Kondo S; Kondo H; Ohsaka A; Fukushima H; Murata R
Toxicon; 1978; 16(3):275-82. PubMed ID: 418535
[No Abstract] [Full Text] [Related]
17. Toxoid of Clostridium botulinum type F: purification and immunogenicity studies.
Hatheway CL
Appl Environ Microbiol; 1976 Feb; 31(2):234-42. PubMed ID: 793522
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of Clostridium septicum alpha-toxoid vaccine against challenge with spores in guinea pigs.
Amimoto K; Ohgitani T; Sasaki O; Oishi E; Katayama S; Isogai M; Ota S
J Vet Med Sci; 2002 Jan; 64(1):67-9. PubMed ID: 11853149
[TBL] [Abstract][Full Text] [Related]
19. [Pseudomonas aeruginosa toxoid].
Ianishevskaia MN
Zh Mikrobiol Epidemiol Immunobiol; 1985 Feb; (2):27-32. PubMed ID: 3922181
[TBL] [Abstract][Full Text] [Related]
20. [Properties of C1. perfringens toxoids obtained from purified toxins].
Dmitrieva LN; Shemanova GF; Vlasova EV; Akhundova KA
Zh Mikrobiol Epidemiol Immunobiol; 1977 Apr; (4):110-4. PubMed ID: 868405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
